Astellas Pharma Inc. (TYO:4503)
Japan · Delayed Price · Currency is JPY 1,615.00
-14.00 (-0.86%)
Aug 27, 2025, 11:30 AM JST
Astellas Pharma Revenue
Astellas Pharma had revenue of 505.79B JPY in the quarter ending June 30, 2025, with 6.91% growth. This brings the company's revenue in the last twelve months to 1.94T, up 14.29% year-over-year. In the fiscal year ending March 31, 2025, Astellas Pharma had annual revenue of 1.91T with 19.25% growth.
Revenue (ttm)
1,944.99B
Revenue Growth
+14.29%
P/S Ratio
1.50
Revenue / Employee
142.56M
Employees
13,643
Market Cap
2,916.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1,912.32B | 308.65B | 19.25% |
| Mar 31, 2024 | 1,603.67B | 85.05B | 5.60% |
| Mar 31, 2023 | 1,518.62B | 222.46B | 17.16% |
| Mar 31, 2022 | 1,296.16B | 46.64B | 3.73% |
| Mar 31, 2021 | 1,249.53B | -51.32B | -3.94% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.21B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Daiichi Sankyo Company | 1,924.68B |
| HOYA Corporation | 876.09B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Shionogi & | 440.50B |
| Olympus | 969.02B |
Astellas Pharma News
- 14 days ago - PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery - Benzinga
- 18 days ago - Astellas Pharma Inc. 2026 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 5 weeks ago - Astellas Announces a Partnership with the "Korea Institute of Startup and Entrepreneurship Development", an Umbrella Organization of the "Ministry of SMEs and Startups", a Korean Government Agency, for the Operation of the "Partnership with Global Companies Program" - PRNewsWire
- 5 weeks ago - China hands 3-1/2-year prison sentence to Astellas' Japanese employee, Nikkei says - Yahoo
- 5 weeks ago - China jails Japanese businessman for espionage, embassy says - Al Jazeera
- 5 weeks ago - Chinese court sentences a Japanese man to more than 3 years in prison on espionage charges - Yahoo
- 6 weeks ago - Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study - Benzinga
- 2 months ago - Mitsubishi Research Institute and Astellas Announce Collaboration to Support Pharma Startups in Japan - PRNewsWire